Series A Biotechnology Companies

Carbon Biosciences is a biotech company that engages in the novel parvovirus gene therapy.

Artio Medical develops endovascular medical devices for the embolization of vessels, aneurysms, and other vascular structures.

Ancora Biotech is a privately held company supporting the clinical development of three multi-specific antibodies.

We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins.

Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.

Synklino is a developer of a CMV-specific immunotoxin intended to eradicate the cytomegalovirus infection.

Code Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies.

Autem Therapeutics is an oncology therapeutic and bioelectric technology company which provides cancer care.

Watchmaker Genomics is a biotechnology company that focuses on breakthrough applications for reading, writing, and editing DNA.

Massive Bio is building the world's largest global real time cancer registry with patient consented clinical and genomic data.

LatchBio is a biotech research company that provides code-free platform for the biocomputing revolution.

MycoMedica Life Sciences, PBC develops fungi-based therapeutic drugs for psychiatric and neurological disorders.

Fluid-Screen is a biotech company that provides chip technology for bacterial capture.

ProFound Therapeutics is creating profound impacts on the understanding of biology and disease and the ability to create therapeutics.

Amytrx Therapeutics is a biopharmaceutical company that advances the next generation of new anti-inflammatory peptide therapies.

Torigen Pharmaceuticals focuses on providing cancer care solutions for animals.

Immunowake is a biotechnology company that focuses on identifying new therapies for patients who do not respond to existing immunotherapies.

VitroLabs develops a platform that manufactures real leather using stem cell-based technologies.

Enumera Molecular is developing a scalable biomolecule assessment platform enabling lower-cost, rapid clinical liquid biopsy tests.

Mazen Animal Health focuses on developing, delivering, and commercializing novel biological vaccines and therapeutics.

Melius Pharma is a pharmaceutical company that focuses on the development of new treatments for interstitial lung diseases.

Developing the first global biosecurity platform to provide enterprises a SaaS-enabled service for the management of bio-risks.

Kelonia Therapeutics develops genetic medicines focused on in vivo gene delivery and cell therapy for cancer and other diseases.

Pheast Therapeutics develops checkpoint therapies to harness the innate immune system.

Apertura Gene Therapy is a biotechnology company that treats debilitating diseases with limited options.